Thursday, May 18, 2017 10:04:28 AM
A trial lawyer with significant civil litigation experience, Mr. Cwik has represented numerous clients in disputes involving patents related to pharmaceuticals, dietary supplements, and medical foods. He also represents clients in patent infringement actions involving abbreviated new drug applications filed with the Food and Drug Administration. Representative drugs involved have included Treanda, Pradaxa, Fosamax, Patanol and Cymbalta. Mr. Cwik’s business litigation experience includes prosecuting and defending numerous state and federal business claims involving the False Claims Act, breach of contract, fraud, replevin, anti-kickback statutes and tortious interference.
Cwik was lead counsel that recently defended an API supplier to a generic pharmaceutical company and forced the brand drug company to withdraw all patent infringement claims against his client resulting in a final termination of the ITC investigation. Later, he challenged the validity of four of those same patents in inter parties review ("IPR") proceedings before the Patent Trial and Appeal Board. In its final written decisions, the Patent Office agreed with his client and held that all 58 out of the 58 challenged claims were invalid or cancelled. These decisions represent the first time a party has successfully defeated a pharma-type patent through the new IPR process. Mr. Cwik also successfully defended on appeal a trial court’s ruling that a patent concerning dietary supplements was invalid.
“Joe has been repeatedly recognized as an Illinois Super Lawyer in the area of intellectual property litigation in 2010, 2012, 2014 and 2015,” said Amin Talati & Upadhye member Rakesh Amin. “We’re delighted to have him on board.”
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM